证券代码：002626 证券简称：金达威 公告编号：2025-056 厦门金达威集团股份有限公司 具体内容详见公司同日在巨潮资讯网（www.cninfo.com.cn）上披露的《关于 再次延长向不特定对象发行可转换公司债券股东大会决议有效期及相关授权有 效期的公告》。 厦门金达威集团股份有限公司（以下简称"公司"）第九届董事会第二次会 议于 2025 年 7 月 16 日在厦门市海沧区公司五层会议室以现场结合通讯表决的 方式召开。本次董事会会议通知已于 2025 年 7 月 11 日以通讯方式发出，并获全 体董事确认。本次会议由公司董事长江斌先生主持，公司董事会成员应到九人， 实际参加表决人数九人。公司副总经理、财务总监、董事会秘书等高级管理人员 亦列席了本次会议。本次会议的召集、召开符合《中华人民共和国公司法》和公 司章程的有关规定。 经与会董事认真审议，本次会议以现场结合通讯表决的方式审议通过了以下 议案： 一、 会议以 9 票同意、0 票反对、0 票弃权的表决结果审议通过《关于再次 延长公司向不特定对象发行可转换公司债券股东大会决议有效期的议案》 本议案尚需提交公司 2025 年第二次临时股东会以特别决 ...

[Xiamen Kingdomway Group Co., Ltd. 2025 H1 Earnings Forecast Analysis](index=1&type=section&id=%E5%8E%A6%E9%97%A8%E9%87%91%E8%BE%BE%E5%A8%81%E9%9B%86%E5%9B%A2%E8%82%A1%E4%BB%BD%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B82025%E5%B9%B4%E5%8D%8A%E5%B9%B4%E5%BA%A6%E4%B8%9A%E7%BB%A9%E9%A2%84%E5%91%8A) [Current Period Performance Forecast](index=1&type=section&id=%E4%B8%80%E3%80%81%E6%9C%AC%E6%9C%9F%E4%B8%9A%E7%BB%A9%E9%A2%84%E8%AE%A1%E6%83%85%E5%86%B5) The company forecasts a 70% to 100% year-over-year increase in net profit for the first half of 2025 2025 H1 Earnings Forecast | Item | Current Period (Jan 1 - Jun 30, 2025) | Same Period Last Year | | :--- | :--- | :--- | | **Net Profit Attributable to Shareholders** | Profit: 221.14 – 260.17 (RMB million) | Profit: 130.08 (RMB million) | | YoY Growth | 70% – 100% | - | | **Net Profit After Non-recurring Items** | Profit: 219.80 – 258.59 (RMB million) | Profit: 129.30 (RMB million) | | YoY Growth | 70% – 100% | - | | **Basic Earnings Per Share (EPS)** | Profit: 0.36 – 0.42 (RMB/Share) | Profit: 0.21 (RMB/Share) | [Communication with the Accounting Firm](index=1&type=section&id=%E4%BA%8C%E3%80%81%E4%B8%8E%E4%BC%9A%E8%AE%A1%E5%B8%88%E4%BA%8B%E5%8A%A1%E6%89%80%E6%B2%9F%E9%80%9A%E6%83%85%E5%86%B5) The company has preliminarily communicated with its auditor on the forecast with no major disagreements - This earnings forecast is **unaudited**, but the company has preliminarily communicated with its accounting firm on related major matters, and **no significant disagreements exist**[4](index=4&type=chunk) [Explanation of Performance Changes](index=1&type=section&id=%E4%B8%89%E3%80%81%E4%B8%9A%E7%BB%A9%E5%8F%98%E5%8A%A8%E5%8E%9F%E5%9B%A0%E8%AF%B4%E6%98%8E) Performance growth is primarily driven by increased sales of key products and domestic healthcare business - The main drivers of performance growth were **increased sales of Coenzyme Q10, Vitamin A, and domestic healthcare products**[5](index=5&type=chunk) [Risk Warning and Explanation](index=1&type=section&id=%E5%9B%9B%E3%80%81%E9%A3%8E%E9%99%A9%E6%8F%90%E7%A4%BA) The company confirms no major uncertainties affecting the forecast but notes the data is unaudited - The company confirms **no significant uncertainties exist** that would affect the accuracy of this earnings forecast[6](index=6&type=chunk) - This forecast is a preliminary estimate by the finance department and is **unaudited**; final data will be based on the official 2025 semi-annual report, and investors should be aware of investment risks[7](index=7&type=chunk)[8](index=8&type=chunk)

Group 1 - The company, Kingdawei (002626), announced an expected net profit for the first half of 2025 ranging from 221 million to 260 million yuan, representing a growth of 70% to 100% compared to the same period last year, which was 130 million yuan [1]

Core Insights - The article discusses recent developments in the nutrition and health industry, highlighting regulatory changes, new product approvals, and market trends that could impact investment opportunities [2][3][4][5][6]. Regulatory Developments - The State Administration for Market Regulation issued a guideline clarifying the definition of commercial advertising under the Advertising Law, addressing ongoing disputes in advertising enforcement [2]. - The National Health Commission approved D-alloheptulose and four other substances as new food raw materials, indicating a push for innovation in the nutrition sector [3]. - The market regulator released multiple responses to proposals regarding health food regulations, signaling a focus on traditional Chinese medicine formulations as a potential growth area [4]. Market Trends and Investment Opportunities - Yangtuo Technology Inc. submitted an IPO application to the Hong Kong Stock Exchange, aiming to raise funds for market expansion and supply chain optimization, reflecting growing investor interest in the nutrition and health sector [5]. - A report on 68 nutrition and health companies showed an average market value increase of 20% in the first half of the year, driven by rising consumer health awareness and demand for nutritional products [6]. Company Performance - New Hope Liuhe (002001) projected a net profit of 3.3 billion to 3.75 billion yuan for the first half of 2025, representing a year-on-year growth of 50% to 70% [12]. - Brother Technology (002562) expects a net profit of 60 million to 75 million yuan for the same period, marking an increase of 325% to 431% compared to the previous year [13]. New Product Launches - Guangji Pharmaceutical (000952) received a notice of administrative penalty for information disclosure violations, indicating regulatory scrutiny in the sector [14]. - TCM brand Tongrentang launched its first OTC glucosamine product, expanding its product line in the bone and joint health category [14].

Group 1 - The health supplement market in China is expected to expand significantly, driven by new demographics and demands, with the vitamin and dietary supplement (VDS) market projected to reach 232.3 billion yuan in 2024, a year-on-year increase of 4% [2] - The market is characterized by high gross margins and marketing expenses, similar to the beauty industry, and is currently undergoing a transformative phase with lower concentration among leading brands [2][3] - New channels and consumer demands are anticipated to drive functionalization in the health supplement industry, creating opportunities for product innovation, particularly through content e-commerce platforms like Douyin [3] Group 2 - Specific categories within the health supplement market are experiencing rapid growth, including fish oil (market size 5-10 billion yuan), coenzyme Q10 (market size 4.1 billion yuan, year-on-year increase of 17%), probiotics (market size over 10 billion yuan), and oral beauty products (market size over 10 billion yuan) [4] - The basic nutrients segment, including vitamins, minerals, and proteins, has a market size of 32.9 billion, 27.1 billion, and 11.6 billion yuan respectively, with year-on-year growth rates of 3%, 5%, and 1%, but faces high product homogeneity [4]

证券代码：002626 证券简称：金达威 公告编号：2025-054 厦门金达威集团股份有限公司 关于变更保荐代表人的公告 特此公告。 厦门金达威集团股份有限公司 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假 记载、误导性陈述或重大遗漏。 厦门金达威集团股份有限公司（以下简称公司）于 2023 年 12 月 22 日收到 深圳证券交易所（以下简称深交所）出具的《关于受理厦门金达威集团股份有限 公司向不特定对象发行可转换公司债券申请文件的通知》（深证上审〔2023〕719 号），于 2024 年 9 月 27 日获深交所上市审核委员会审核通过，于 2024 年 11 月 19 日收到中国证券监督管理委员会出具的《关于同意厦门金达威集团股份有限 公司向不特定对象发行可转换公司债券注册的批复》（证监许可〔2024〕1567 号）。 近日，公司收到广发证券股份有限公司（以下简称广发证券）《关于变更厦 门金达威集团股份有限公司保荐代表人的通知》，广发证券作为公司 2023 年度向 不特定对象发行可转换公司债券的保荐人，原指定孙昭伟先生、李晓芳女士担任 该项目的保荐代表人。现因李晓芳女士工作变动，不 ...

证券代码：002626 证券简称：金达威 公告编号：2025-053 厦门金达威集团股份有限公司 关于控股股东部分股份解除质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 厦门金达威集团股份有限公司（以下简称公司）近日收到公司控股股东厦 门金达威投资有限公司（以下简称金达威投资）将其所持有的本公司部分股票 解除质押的通知，现将有关事项公告如下： 一、 股东股份解除质押的基本情况 | | | | | | | 已质押股 | | 未质押 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | | | | | | | 股份情 | | | | | | | | | 份情况 | | 况 | | | | | | | 合计占 | 合计占 | | | 未 | | | 股东名称 | 持股数量 | 持股比 | 累计被质 押股份数 | 其所持 | 公司总 | 已质 押股 | 占 已 | 质 | 占 未 | | | （股） | 例 | 量（股） | 股份比 例 | 股本比 例 | 份限 | ...

（原标题：食品饮料行业6月23日资金流向日报） 沪指6月23日上涨0.65%，申万所属行业中，今日上涨的有28个，涨幅居前的行业为计算机、国防军工，涨幅分别为2.25%、1.97%。跌幅居前的行 业为食品饮料、家用电器、钢铁，跌幅分别为0.80%、0.43%、0.11%。食品饮料行业位居今日跌幅榜首位。 食品饮料行业今日下跌0.80%，全天主力资金净流出6.93亿元，该行业所属的个股共123只，今日上涨的有75只；下跌的有44只。以资金流向数据 进行统计，该行业资金净流入的个股有56只，其中，净流入资金超千万元的有7只，净流入资金居首的是泸州老窖，今日净流入资金6440.25万 元，紧随其后的是东鹏饮料、金达威，净流入资金分别为2834.50万元、2093.72万元。食品饮料行业资金净流出个股中，资金净流出超3000万元的 有8只，净流出资金居前的有贵州茅台、伊利股份、洋河股份，净流出资金分别为3.72亿元、6277.42万元、5528.86万元。（数据宝） 食品饮料行业资金流入榜 | 代码 | 简称 | 今日涨跌幅（%） | 今日换手率（%） | 主力资金流量（万元） | | --- | --- | --- ...

Core Viewpoint - Xiamen Jindawei Group Co., Ltd. announced the pledge and release of shares by its controlling shareholder, Xiamen Jindawei Investment Co., Ltd., indicating ongoing financial maneuvers within the company [1][2]. Group 1: Share Pledge Details - The controlling shareholder pledged 10,200,000 shares, representing 4.82% of its holdings and 1.67% of the company's total share capital, with the pledge starting on June 20, 2025 [1]. - The shareholder also released 15,170,000 shares from pledge, which accounted for 7.17% of its holdings and 2.49% of the company's total share capital, with the pledge starting on June 21, 2022, and set to be released on June 20, 2025 [1][2]. - As of the announcement date, the total pledged shares by the controlling shareholder amounted to 211,712,732 shares, which is 34.71% of its holdings [2]. Group 2: Ongoing Monitoring - The company will continue to monitor the share pledge situation and associated risks, ensuring compliance with relevant disclosure obligations [2].

厦门金达威集团股份有限公司 关于控股股东部分股份质押及解除质押的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 厦门金达威集团股份有限公司（以下简称公司）近日收到公司控股股东厦门 金达威投资有限公司（以下简称金达威投资）将其所持有的公司部分股票进行股 票质押及解除质押的通知，现将有关事项公告如下： 证券代码：002626 证券简称：金达威 公告编号：2025-052 2．本次解除质押基本情况 | 股东 | 是否为控 股股东或 | 本次解除质 | 占其所 | 占公司总 | | | | | --- | --- | --- | --- | --- | --- | --- | --- | | 名称 | 第一大股 | 押股份数量 | 持股份 | 股本比例 | 起始日 | 解除日期 | 质权人 | | | 东及其一 | （股） | 比例 | | | | | | | 致行动人 | | | | | | | | 金达 | | | | | | | 中国中金财 | | 威投 | 是 | 15,170,000 | 7.17% | 2.49% | 2022.6.21 | 2025 ...